Luteolin Attenuates Hypertension via Inhibiting NF-κB-Mediated Inflammation and PI3K/Akt Signaling Pathway in the Hypothalamic Paraventricular Nucleus

• Published in: Nutrients 2023-01, Vol.15 (3), p.502
• Main Authors: Gao, Hong-Li, Yu, Xiao-Jing, Feng, Yu-Qi, Yang, Yu, Hu, Han-Bo, Zhao, Yu-Yang, Zhang, Jia-Hao, Liu, Kai-Li, Zhang, Yan, Fu, Li-Yan, Li, Ying, Qi, Jie, Qiao, Jin-An, Kang, Yu-Ming
• Format: Article
• Language: English
• Subjects: 1-Phosphatidylinositol 3-kinase; AKT protein; Alzheimer's disease; Animals; Bioflavonoids; Blood pressure; Cerebrospinal fluid; CYBB protein; Cytokines; Development and progression; Diet therapy; Epinephrine; Flavones; Flavonoids; Free radicals; Gene expression; Glutamate decarboxylase; Health aspects; Heart rate; Hemodynamics; Hypertension; hypothalamic paraventricular nucleus; Hypothalamus; Immunofluorescence; infammatory cytokines; Inflammation; Inflammation - metabolism; Kinases; Laboratory animals; luteolin; Luteolin - pharmacology; Luteolin - therapeutic use; NAD(P)H oxidase; NF-kappa B - metabolism; NF-κB protein; Norepinephrine; NOX4 protein; Oxidative stress; Paraventricular Hypothalamic Nucleus - metabolism; Paraventricular nucleus; Phosphatidylinositol 3-Kinases - metabolism; Physiological aspects; PI3K/Akt/NF-κB signaling pathway; Proto-Oncogene Proteins c-akt - metabolism; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive oxygen species; Scavenging; Signal Transduction; Software; Superoxide dismutase; Sympathetic Nervous System; Tyrosine; Tyrosine 3-monooxygenase
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15030502

Luteolin is widely distributed among a number of vegetal species worldwide. The pharmacological effects of luteolin are diverse and amongst antioxidant, free radical scavenging, and anti-inflammatory activities. Preliminary study showed that luteolin can ameliorate hypertension. However, the precise mechanism needs further investigation. There is no evidence that luteolin affects the paraventricular nucleus of the hypothalamus (PVN), a brain nucleus associated with a critical neural regulator of blood pressure. Our main aim was to explore the effect of luteolin on the PI3K/Akt/NF-κB signaling pathway within the PVN of hypertensive rats. spontaneously hypertensive rats (SHRs) and corresponding normotensive control rats, the Wistar Kyoto (WKY) rats were divided into four groups and subsequently treated for 4 weeks with bilateral PVN injections of either luteolin (20 µg/0.11 µL, volume: 0.11 µL/h) or vehicle (artificial cerebrospinal fluid). luteolin infusion to the PVN significantly decreased some hemodynamic parameters including the mean arterial pressure (MAP), heart rate (HR), circulating plasma norepinephrine (NE) and epinephrine (EPI). Additionally, there was a decrease in the expressions of the phosphatidylinositol 3-kinase (p-PI3K) and phosphorylated protein kinase-B (p-AKT), levels of reactive oxygen species (ROS), NAD(P)H oxidase subunit (NOX2, NOX4) in the PVN of SHRs. Meanwhile, the expression of inflammatory cytokines and the activity of nuclear factor κB (NF-κB) p65 in the PVN of SHRs were lowered. Furthermore, immunofluorescence results showed that injection of luteolin in the PVN reduced the expression of tyrosine hydroxylase (TH), and increased that of superoxide dismutase (SOD1) and the 67-kDa isoform of glutamate decarboxylase (GAD67) in the PVN of SHRs. Our novel findings revealed that luteolin lowered hypertension via inhibiting NF-κB-mediated inflammation and PI3K/Akt signaling pathway in the PVN.